Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Papa Johns teams up with Disney and Pixar for Toy Story 5

    August 7, 2026

    Himel Brings Its Residential Vision to Life Through the Global Dream Home Campaign

    August 7, 2026

    Truecaller Ads Launches ‘Truecaller Pulse’; An Industry First Declared Intent Media Solution

    August 6, 2026
    Facebook X (Twitter) Instagram
    • Home
    • Contact Us
    KES DailyKES Daily
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • More
      • News
      • Sports
      • Technology
      • Travel
    KES DailyKES Daily
    Home » BioMed X Launches a New Call for Application in Autoimmune Disease Research
    ACCESS Newswire

    BioMed X Launches a New Call for Application in Autoimmune Disease Research

    November 7, 2023
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.

    HEIDELBERG, GERMANY / ACCESSWIRE / November 7, 2023 / BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease.

    Current therapeutic strategies for autoimmune diseases primarily focus on broadly suppressing the immune response, with significant side effects. More importantly, none of these treatments address one of the root causes of the disease, the autoreactive plasma cells that produce antibodies targeting self-antigens. By exploring the deep biology of human autoreactive plasma cells to identify biomarkers that distinguish them from their physiological counterparts, this project aims to identify new therapeutic strategies to selectively eliminate these cells in patients suffering from autoimmune diseases.

    “Immunology – including autoimmunity – is one of our R&D focus areas at our BioMed X Institutes in Heidelberg, New Haven, and our XSeed Labs in Ridgefield. Currently, we are hosting five immunology research teams at different stages of development. We are excited to extend our immunology research capabilities with this new project in the field of autoreactive plasma cells,” explains Christian Tidona, Founder and Managing Director of the BioMed X Institute.

    This new research group will be located at the BioMed X Institute in Heidelberg, Germany. Each BioMed X project is a collaboration with a leading pharmaceutical company. To learn more about this project and how to apply, visit the BioMed X Career Space at https://career.bio.mx/call/2023-BMX-C02. The deadline for applying is January 7, 2023.

    About BioMed X

    BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.

    Contact Information:

    Flavia-Bianca Cristian
    Recruiting & Communications Manager
    fbc@bio.mx
    +49 6221 426 11 706

    Related Images

    SOURCE: BioMed X Institute

    View source version on accesswire.com:
    https://www.accesswire.com/800139/biomed-x-launches-a-new-call-for-application-in-autoimmune-disease-research

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    ACCESS Newswire

    Kleen Hy-Dro-Gen Inc. Is Pleased to Announce Dual ISO 9001:2015 and TSSA Certifications, Bolstering Operational Quality and Technical Safety Governance

    August 5, 2026
    ACCESS Newswire

    Kleen Hy-Dro-Gen Inc. Is Pleased to Announce Dual ISO 9001:2015 and TSSA Certifications, Bolstering Operational Quality and Technical Safety Governance

    August 5, 2026
    ACCESS Newswire

    Review of 31 Studies Finds Vegan Dog Food and Vegan Cat Food Are Well Digested

    July 31, 2026
    Editor's Pick

    China adds drone curbs and restrictions on US entities

    August 6, 2026

    OECD inflation falls to 4.2% and energy price pressures cool

    August 5, 2026

    Brent and WTI extend losses after sharp crude market selloff

    August 5, 2026

    New Ebola vaccine enters human trial as Congo cases rise

    August 5, 2026

    Fuego volcano eruption puts Guatemala regions on red alert

    August 5, 2026

    Michigan outbreak update confirms two cyclospora deaths

    August 4, 2026

    Eastern Washington wildfires force 67,000 evacuations

    August 4, 2026
    News

    China adds drone curbs and restrictions on US entities

    August 6, 2026

    Fuego volcano eruption puts Guatemala regions on red alert

    August 5, 2026

    Eastern Washington wildfires force 67,000 evacuations

    August 4, 2026
    Business

    OECD inflation falls to 4.2% and energy price pressures cool

    August 5, 2026

    Brent and WTI extend losses after sharp crude market selloff

    August 5, 2026

    Oil prices surge past $90 then retreat on market shifts

    August 3, 2026
    Travel

    Guggenheim Abu Dhabi to open 11th December 2026

    July 29, 2026

    Emirates launches cryptocurrency payment option for flight bookings

    July 29, 2026

    flydubai Bangkok flights rise to 14 weekly services

    July 16, 2026
    © 2026 KES Daily | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.